BRAF and central nervous system cancer: Incidence and interplay of the presence of BRAF V600E mutation and 9p21 region deletion was evaluated in a series of 78 LGG and 22 HGG aiming to determine the role of these two alterations in recurrence and gliomas’ malignant transformation.